152 related articles for article (PubMed ID: 9684714)
1. Use of exogenous hormones hormones and risk of papillary thyroid cancer (Washington, United States).
Rossing MA; Voigt LF; Wicklund KG; Williams M; Daling JR
Cancer Causes Control; 1998 May; 9(3):341-9. PubMed ID: 9684714
[TBL] [Abstract][Full Text] [Related]
2. Risk of papillary thyroid cancer in women in relation to smoking and alcohol consumption.
Rossing MA; Cushing KL; Voigt LF; Wicklund KG; Daling JR
Epidemiology; 2000 Jan; 11(1):49-54. PubMed ID: 10615843
[TBL] [Abstract][Full Text] [Related]
3. Incidence of thyroid cancer in women in relation to reproductive and hormonal factors.
McTiernan AM; Weiss NS; Daling JR
Am J Epidemiol; 1984 Sep; 120(3):423-35. PubMed ID: 6475918
[TBL] [Abstract][Full Text] [Related]
4. Reproductive and menstrual history and papillary thyroid cancer risk: the San Francisco Bay Area thyroid cancer study.
Sakoda LC; Horn-Ross PL
Cancer Epidemiol Biomarkers Prev; 2002 Jan; 11(1):51-7. PubMed ID: 11815401
[TBL] [Abstract][Full Text] [Related]
5. Breast cancer among young U.S. women in relation to oral contraceptive use.
White E; Malone KE; Weiss NS; Daling JR
J Natl Cancer Inst; 1994 Apr; 86(7):505-14. PubMed ID: 8133534
[TBL] [Abstract][Full Text] [Related]
6. Reproductive history and cigarette smoking as risk factors for thyroid cancer in women: a population-based case-control study.
Galanti MR; Hansson L; Lund E; Bergström R; Grimelius L; Stalsberg H; Carlsen E; Baron JA; Persson I; Ekbom A
Cancer Epidemiol Biomarkers Prev; 1996 Jun; 5(6):425-31. PubMed ID: 8781737
[TBL] [Abstract][Full Text] [Related]
7. A pooled analysis of case-control studies of thyroid cancer. III. Oral contraceptives, menopausal replacement therapy and other female hormones.
La Vecchia C; Ron E; Franceschi S; Dal Maso L; Mark SD; Chatenoud L; Braga C; Preston-Martin S; McTiernan A; Kolonel L; Mabuchi K; Jin F; Wingren G; Galanti MR; Hallquist A; Lund E; Levi F; Linos D; Negri E
Cancer Causes Control; 1999 Apr; 10(2):157-66. PubMed ID: 10231164
[TBL] [Abstract][Full Text] [Related]
8. Recreational physical activity and risk of papillary thyroid cancer (United States).
Rossing MA; Remler R; Voigt LF; Wicklund KG; Daling JR
Cancer Causes Control; 2001 Dec; 12(10):881-5. PubMed ID: 11808706
[TBL] [Abstract][Full Text] [Related]
9. Use of low-dose oral contraceptives and stroke in young women.
Schwartz SM; Siscovick DS; Longstreth WT; Psaty BM; Beverly RK; Raghunathan TE; Lin D; Koepsell TD
Ann Intern Med; 1997 Oct; 127(8 Pt 1):596-603. PubMed ID: 9341057
[TBL] [Abstract][Full Text] [Related]
10. Reproductive factors and risk of papillary thyroid cancer in women.
Rossing MA; Voigt LF; Wicklund KG; Daling JR
Am J Epidemiol; 2000 Apr; 151(8):765-72. PubMed ID: 10965973
[TBL] [Abstract][Full Text] [Related]
11. Epidemiology of reproductive and hormonal factors in thyroid cancer: evidence from a case-control study in the Middle East.
Memon A; Darif M; Al-Saleh K; Suresh A
Int J Cancer; 2002 Jan; 97(1):82-9. PubMed ID: 11774247
[TBL] [Abstract][Full Text] [Related]
12. Hormonal and reproductive influences and risk of melanoma in women.
Smith MA; Fine JA; Barnhill RL; Berwick M
Int J Epidemiol; 1998 Oct; 27(5):751-7. PubMed ID: 9839729
[TBL] [Abstract][Full Text] [Related]
13. Menstrual and reproductive factors in the risk of thyroid cancer in Japanese women: the Japan Public Health Center-Based Prospective Study.
Shin S; Sawada N; Saito E; Yamaji T; Iwasaki M; Shimazu T; Sasazuki S; Inoue M; Tsugane S;
Eur J Cancer Prev; 2018 Jul; 27(4):361-369. PubMed ID: 28118209
[TBL] [Abstract][Full Text] [Related]
14. Hormonal factors and the risk of papillary thyroid cancer in the California Teachers Study cohort.
Horn-Ross PL; Canchola AJ; Ma H; Reynolds P; Bernstein L
Cancer Epidemiol Biomarkers Prev; 2011 Aug; 20(8):1751-9. PubMed ID: 21791618
[TBL] [Abstract][Full Text] [Related]
15. Menstrual and reproductive factors in the risk of differentiated thyroid carcinoma in young women in France: a population-based case-control study.
Xhaard C; Rubino C; Cléro E; Maillard S; Ren Y; Borson-Chazot F; Sassolas G; Schvartz C; Colonna M; Lacour B; Danzon A; Velten M; Buemi A; Bailly L; Mariné Barjoan E; Schlumberger M; Orgiazzi J; Adjadj E; de Vathaire F
Am J Epidemiol; 2014 Nov; 180(10):1007-17. PubMed ID: 25269571
[TBL] [Abstract][Full Text] [Related]
16. Oral contraceptives and breast cancer risk among younger women.
Brinton LA; Daling JR; Liff JM; Schoenberg JB; Malone KE; Stanford JL; Coates RJ; Gammon MD; Hanson L; Hoover RN
J Natl Cancer Inst; 1995 Jun; 87(11):827-35. PubMed ID: 7791232
[TBL] [Abstract][Full Text] [Related]
17. Combined effect of oral contraceptive use and hormone replacement therapy on breast cancer risk in postmenopausal women.
Norman SA; Berlin JA; Weber AL; Strom BL; Daling JR; Weiss LK; Marchbanks PA; Bernstein L; Voigt LF; McDonald JA; Ursin G; Liff JM; Burkman RT; Malone KE; Simon MS; Folger SG; Deapen D; Wingo PA; Spirtas R
Cancer Causes Control; 2003 Dec; 14(10):933-43. PubMed ID: 14750532
[TBL] [Abstract][Full Text] [Related]
18. Female thyroid cancer: the role of reproductive and hormonal factors in Switzerland.
Levi F; Franceschi S; Gulie C; Negri E; La Vecchia C
Oncology; 1993; 50(4):309-15. PubMed ID: 8497382
[TBL] [Abstract][Full Text] [Related]
19. Reproductive and hormonal risk factors for thyroid cancer in Los Angeles County females.
Mack WJ; Preston-Martin S; Bernstein L; Qian D; Xiang M
Cancer Epidemiol Biomarkers Prev; 1999 Nov; 8(11):991-7. PubMed ID: 10566554
[TBL] [Abstract][Full Text] [Related]
20. Papillary thyroid cancer incidence in the volcanic area of Sicily.
Pellegriti G; De Vathaire F; Scollo C; Attard M; Giordano C; Arena S; Dardanoni G; Frasca F; Malandrino P; Vermiglio F; Previtera DM; D'Azzò G; Trimarchi F; Vigneri R
J Natl Cancer Inst; 2009 Nov; 101(22):1575-83. PubMed ID: 19893009
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
